Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Rozendaal L, Heideman DA, Verheijen RH, Bulk S, Verweij W, Snijders PJ, Meijer CJ.
Br J Cancer. 2012 Feb 28;106(5):975-81. doi: 10.1038/bjc.2011.581. Epub 2012 Jan 17.
Related citations
Antichlamydial antibodies, human fertility, and pregnancy wastage.
Stephens AJ, Aubuchon M, Schust DJ.
Infect Dis Obstet Gynecol. 2011;2011:525182. Epub 2011 Sep 22. Review.
Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap samples and the role of pre- and postcytology testing.
Chernesky M, Jang D, Portillo E, Smieja M, Kapala J, Doucette C, Sumner J, Ewert R, MacRitchie C, Gilchrist J.
J Clin Microbiol. 2012 Apr;50(4):1281-4. Epub 2012 Jan 18.
Validation of reverse sequence screening for syphilis.
Lipinsky D, Schreiber L, Kopel V, Shainberg B.
J Clin Microbiol. 2012 Apr;50(4):1501. Epub 2012 Jan 18. No abstract available.
Time to refocus on HSV interventions for HIV prevention?
Tanton C, Abu-Raddad LJ, Weiss HA.
J Infect Dis. 2011 Dec 15;204(12):1822-6. Epub 2011 Oct 12. No abstract available.
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
Mugwanya K, Baeten JM, Mugo NR, Irungu E, Ngure K, Celum C.
J Infect Dis. 2011 Dec 15;204(12):1912-7. Epub 2011 Oct 12.
A laboratory-based evaluation of the BioStar Optical ImmunoAssay point-of-care test for diagnosing Neisseria gonorrhoeae infection.
Samarawickrama A, Alexander S, Ison C.
J Med Microbiol. 2011 Dec;60(Pt 12):1779-81. Epub 2011 Aug 11.
Mandatory HPV vaccination.
Tomljenovic L, Shaw CA.
JAMA. 2012 Jan 18;307(3):254; author reply 254-5. No abstract available.
Berger LC, Blog D, Birkhead GS.
JAMA. 2012 Jan 18;307(3):253-4; author reply 254-5. No abstract available.
Gilkey MB, Brewer NT.
JAMA. 2012 Jan 18;307(3):252-3; author reply 254-5. No abstract available.
Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”.
Cohen MS, Eron JJ Jr.
Sex Transm Dis. 2011 May;38(5):410-2. No abstract available.
Emergence of herpes simplex virus-1 syncytial variants with altered virulence for mice after selection with a natural carrageenan.
Mateu CG, Recalde MP, Artuso MC, Hermida G, Linero FN, Scolaro LA, Damonte EB, Pujol CA, Carlucci MJ.
Sex Transm Dis. 2011 Jun;38(6):555-61.
The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries.
Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield HH, Pequegnat W, Mayer K, Hartwell TD, Quinn TC.
Sex Transm Dis. 2011 Jun;38(6):503-9.
Chlamydia trachomatis in the age of the genome: application of molecular genotyping to improve our understanding of the immunopathogenesis of Chlamydia genital tract disease.
Turner K, Clarke I, Timpson N, Horner P.
Sex Transm Dis. 2011 Jun;38(6):495-8. No abstract available.
Prevalence and concordance of HPV, HIV, and HSV-2 in heterosexual couples in Kigali, Rwanda.
Veldhuijzen NJ, Dhont N, Vyankandondera J, Gasarabwe A, Busasa R, Crucitti T, van de Wijgert JH.
Sex Transm Dis. 2012 Feb;39(2):128-35.
Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.
Datta SD, Torrone E, Kruszon-Moran D, Berman S, Johnson R, Satterwhite CL, Papp J, Weinstock H.
Sex Transm Dis. 2012 Feb;39(2):92-6.
Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population.
Scholes D, Satterwhite CL, Yu O, Fine D, Weinstock H, Berman S.
Sex Transm Dis. 2012 Feb;39(2):81-8.
HIV screening in commercially insured patients screened or diagnosed with sexually transmitted diseases or blood-borne pathogens.
Chen JY, Ma Q, Everhard F, Yermilov I, Tian H, Mayer KH.
Sex Transm Dis. 2011 Jun;38(6):522-7.
The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
Vickerman P, Devine A, Foss AM, Delany-Moretlwe S, Mayaud P, Meyer-Rath G.
Sex Transm Dis. 2011 May;38(5):401-9.
Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
Roth AM, Williams JA, Ly R, Curd K, Brooks D, Arno J, Van Der Pol B.
Sex Transm Dis. 2011 May;38(5):398-400.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on